ES544075A0 - PROCEDURE FOR PREPARING A SOLID DISPERSION OF A PHARMACOLOGICALLY ACTIVE DISHYDROPYRIDINE IN A CRYSTAL MATRIX AS A VEHICLE. - Google Patents

PROCEDURE FOR PREPARING A SOLID DISPERSION OF A PHARMACOLOGICALLY ACTIVE DISHYDROPYRIDINE IN A CRYSTAL MATRIX AS A VEHICLE.

Info

Publication number
ES544075A0
ES544075A0 ES544075A ES544075A ES544075A0 ES 544075 A0 ES544075 A0 ES 544075A0 ES 544075 A ES544075 A ES 544075A ES 544075 A ES544075 A ES 544075A ES 544075 A0 ES544075 A0 ES 544075A0
Authority
ES
Spain
Prior art keywords
dishydropyridine
preparing
procedure
vehicle
pharmacologically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES544075A
Other languages
Spanish (es)
Other versions
ES8702141A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES8702141A1 publication Critical patent/ES8702141A1/en
Publication of ES544075A0 publication Critical patent/ES544075A0/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ES544075A 1984-06-14 1985-06-12 Galenical retard formulations Expired ES8702141A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3422083 1984-06-14
DE3442566 1984-11-22

Publications (2)

Publication Number Publication Date
ES8702141A1 ES8702141A1 (en) 1987-01-01
ES544075A0 true ES544075A0 (en) 1987-01-01

Family

ID=25822108

Family Applications (1)

Application Number Title Priority Date Filing Date
ES544075A Expired ES8702141A1 (en) 1984-06-14 1985-06-12 Galenical retard formulations

Country Status (21)

Country Link
AT (1) AT391806B (en)
AU (2) AU587190B2 (en)
BE (1) BE902626A (en)
CA (1) CA1264441A (en)
CY (1) CY1635A (en)
DE (1) DE3520184C2 (en)
DK (1) DK167649B1 (en)
ES (1) ES8702141A1 (en)
FR (1) FR2565822B1 (en)
GB (3) GB2160100B (en)
GR (1) GR851430B (en)
HK (1) HK25192A (en)
HU (1) HU198844B (en)
IE (1) IE58834B1 (en)
IL (1) IL75490A0 (en)
IT (1) IT1200080B (en)
LU (1) LU85946A1 (en)
NL (1) NL194389C (en)
NZ (1) NZ212390A (en)
PT (1) PT80635B (en)
SE (1) SE504583C2 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1187751B (en) * 1985-10-15 1987-12-23 Eurand Spa PROCEDURE FOR THE PREPARATION OF SOLID FORMULATIONS OF NIFEDIPINE WITH HIGH BIO AVAILABILITY AND WITH PROLONGED EFFECT AND FORMULATIONS SO OBTAINED
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
EP0406315B1 (en) * 1988-03-24 1992-11-11 Bukh Meditec A/S Controlled release composition
GR1000270B (en) * 1988-09-30 1992-05-12 Alza Corp Dose for cardiovascular troubles therapy
DK469989D0 (en) * 1989-09-22 1989-09-22 Bukh Meditec PHARMACEUTICAL PREPARATION
MX9300110A (en) * 1992-01-13 1994-07-29 Gerhard Gergely PHARMACEUTICAL PREPARATION IN THE FORM OF AN EFFERVESCENCE OR DISINTEGRATION TABLET OR OF AN INSTANT-TYPE GRANULATE AND PROCEDURE FOR ITS PREPARATION.
DE4201179A1 (en) * 1992-01-17 1993-07-22 Alfatec Pharma Gmbh Granulates or pellets comprising dispersion of active agent in hydrophilic macromolecules - are e.g. for treatment of depression, hypertension, rheumatism, etc.
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US6726930B1 (en) 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
WO1998001117A1 (en) 1996-07-08 1998-01-15 Edward Mendell Co., Inc. Sustained release matrix for high-dose insoluble drugs
DE19710009A1 (en) * 1997-03-12 1998-09-24 Knoll Ag Multi-phase preparation forms containing active ingredients
US6056977A (en) * 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US6787157B1 (en) 1998-03-10 2004-09-07 Abbott Laboratories Multiphase active ingredient-containing formulations
EP1189599A2 (en) * 1999-06-11 2002-03-27 Eli Lilly And Company Pharmaceutical materials and methods for their preparation and use
US7001892B1 (en) 1999-06-11 2006-02-21 Purdue Research Foundation Pharmaceutical materials and methods for their preparation and use
JP3462490B2 (en) * 1999-08-04 2003-11-05 山之内製薬株式会社 Stable oral pharmaceutical composition
IL143375A0 (en) 1999-09-30 2002-04-21 Penwest Pharmaceuticals Co Sustained release matrix systems for highly soluble drugs
CA2434835A1 (en) * 2001-02-13 2002-08-22 Astrazeneca Ab Novel modified released formulation
US7135436B2 (en) 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
EP1690528A1 (en) 2005-02-11 2006-08-16 Abbott GmbH & Co. KG Process for the preparation of dosage forms comprising a solid dispersion of a microcrystalline active agent
WO2008070118A1 (en) 2006-12-05 2008-06-12 Landec Corporation Drug delivery
US8399007B2 (en) 2006-12-05 2013-03-19 Landec Corporation Method for formulating a controlled-release pharmaceutical formulation
US8114883B2 (en) 2007-12-04 2012-02-14 Landec Corporation Polymer formulations for delivery of bioactive materials
MX2011001864A (en) * 2008-08-20 2011-06-20 Univ Texas Hot-melt extrusion of modified release multi-particulates.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617362A1 (en) * 1967-11-17 1971-03-25 Beiersdorf Ag Process for the production of medicaments with delayed release of active substances in the form of capsules
DE2400819C2 (en) * 1974-01-09 1982-04-22 Bayer Ag, 5090 Leverkusen Process for the production of solid preparations of poorly soluble active pharmaceutical ingredients in extremely fine distribution
DE2546577B2 (en) * 1975-10-17 1981-04-02 Sandoz-Patent-GmbH, 7850 Lörrach Solid substances made from polyvinylpyrrolidone and ergot alkaloids
GB1504553A (en) * 1975-11-17 1978-03-22 Sandoz Ltd Tablet formulations
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
CH639659A5 (en) * 1978-12-18 1983-11-30 Sandoz Ag NEW 1,4-DIHYDROPYRIDINE DERIVATIVES, THEIR PRODUCTION AND USE.
FI64938C (en) * 1977-06-20 1984-02-10 Sandoz Ag PROCEDURE FOR THE FRAMEWORK OF THERAPEUTIC THERAPEUTIC BENSOX A- AND OX BENZOTIADIAZOLYL-1,4-DIHYDROPYRID DERIVATIVES
EP0001247A1 (en) * 1977-09-14 1979-04-04 Kanebo, Ltd. Pharmaceutical preparation containing nifedipine and a method for producing the same.
DK154607C (en) * 1978-12-21 1989-06-05 Sandoz Ag PROCEDURE FOR PREPARING A PHARMACEUTICAL FORM FOR ORAL ADMINISTRATION OF ERGOTAL KALOIDS
DE2904310A1 (en) * 1979-02-05 1980-08-07 Boehringer Mannheim Gmbh MOLDINGS WITH RETARDED ACTIVE SUBSTANCE RELEASE AND METHOD FOR THE PRODUCTION THEREOF
JPS56115726A (en) * 1980-02-20 1981-09-11 Kaken Pharmaceut Co Ltd Pharmaceutical containing nifedipine
DE3033919A1 (en) * 1980-09-09 1982-04-22 Bayer Ag, 5090 Leverkusen SOLID PHARMACEUTICAL PREPARATIONS CONTAINING NIFEDIPINE AND METHOD FOR THE PRODUCTION THEREOF
US4442112A (en) * 1981-09-02 1984-04-10 Sandoz Ltd. Dihydropyridine derivatives useful in treating vascular headaches
DE3270785D1 (en) * 1981-10-29 1986-05-28 Bayer Ag Process for preparing solid fast-releasing drug formulations of dihydropyridines
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
DE3318649A1 (en) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen TWO-PHASE FORMULATION

Also Published As

Publication number Publication date
GB8727056D0 (en) 1987-12-23
SE8502950D0 (en) 1985-06-13
HU198844B (en) 1989-12-28
GB8514855D0 (en) 1985-07-17
FR2565822B1 (en) 1989-02-17
GB2196852A (en) 1988-05-11
BE902626A (en) 1985-12-10
NL194389B (en) 2001-11-01
NL194389C (en) 2002-03-04
PT80635A (en) 1985-07-01
ATA174885A (en) 1990-06-15
PT80635B (en) 1987-10-20
SE504583C2 (en) 1997-03-10
CA1264441A (en) 1990-01-16
LU85946A1 (en) 1986-01-24
GB2160100A (en) 1985-12-18
DE3520184C2 (en) 1997-03-13
GB2196852B (en) 1989-05-17
DK167649B1 (en) 1993-12-06
DK264785D0 (en) 1985-06-12
ES8702141A1 (en) 1987-01-01
HK25192A (en) 1992-04-10
DE3520184A1 (en) 1985-12-19
GB8727055D0 (en) 1987-12-23
DK264785A (en) 1985-12-15
IE851460L (en) 1985-12-14
AU4348685A (en) 1985-12-19
SE8502950L (en) 1985-12-15
GR851430B (en) 1985-11-25
GB2196851B (en) 1989-06-07
NZ212390A (en) 1992-02-25
CY1635A (en) 1992-11-06
IL75490A0 (en) 1985-10-31
IT8548210A0 (en) 1985-06-13
AT391806B (en) 1990-12-10
GB2196851A (en) 1988-05-11
GB2160100B (en) 1989-06-01
FR2565822A1 (en) 1985-12-20
IT1200080B (en) 1989-01-05
AU587190B2 (en) 1989-08-10
IE58834B1 (en) 1993-11-17
HUT40918A (en) 1987-03-30
NL8501578A (en) 1986-01-02
AU4454389A (en) 1990-03-22

Similar Documents

Publication Publication Date Title
ES544075A0 (en) PROCEDURE FOR PREPARING A SOLID DISPERSION OF A PHARMACOLOGICALLY ACTIVE DISHYDROPYRIDINE IN A CRYSTAL MATRIX AS A VEHICLE.
ES541503A0 (en) A METHOD FOR PREPARING A SOLID, THERAPEUTICALLY ACTIVE UNIT DOSAGE FORM
MX27046A (en) 5-ARILALQUIL-4-ALCOXY-2 (5H) -FURANONAS, INTERMEDIATE PRODUCTS AND PROCEDURE FOR ITS PREPARATION AS WELL AS ITS APPLICATION AS AN ACTIVE THERAPEUTIC SUBSTANCE.
AR230569A1 (en) METHOD FOR THE PREPARATION OF A SOLID UNIT THERAPEUTICALLY ACTIVE POSOLOGICAL FORM, WITH REGULAR AND PROLONGED RELEASE GUIDELINE ON BEING ADMINISTERED
ES539432A0 (en) A PROCEDURE FOR PREPARING A FIBRINOLYTICALLY ACTIVE PROTEIN CONJUGATE
ES494274A0 (en) PROCEDURE FOR OBTAINING A DIVISIBLE TABLET CONTROLLED AND DELAYED CONCESSION OF THE ACTIVE SUBSTANCE
ES511169A0 (en) PROCEDURE FOR PREPARING A PENETRABLE COMPOSITION FOR SKIN BASED ON SYSTEMICALLY ACTIVE THERAPEUTIC AGENTS
MX158030A (en) LIQUID COMPOSITION MAINLY FOR ACTIVE SUBSTANCE VEHICLE AGAINST SWEAT
AU558304B2 (en) Matrix composition for transdermal therapeutic system
ES557677A0 (en) A PROCEDURE FOR PREPARING A FIBRINOLYTICALLY ACTIVE HYBRID PROTEIN.
NO884068D0 (en) PROCEDURE FOR AA FLEXIBRIC PHOTOPOLYMER PRINT PLATES.
DE3884891D1 (en) Active matrix cell and its manufacturing process.
AU1008388A (en) Presulfiding composition for preparing hydrotreating catalyst activity
MX163193B (en) IMPROVEMENTS IN TRACTOR TIRE
MX12038A (en) URETHANE COMPOSITION TO MANUFACTURE STEERING WHEELS.
AU513669B2 (en) Manufacturing prestressed construction elements ina long mould bed
IT8467584A0 (en) PROCEDURE FOR RENDERING A SYNTHETIC VACUOLATED SHEET MATERIAL, PARTICULARLY A SYNTHETIC LEATHER, INCOMBUSTIBLE
MX7644E (en) ENZYMATIC PROCEDURE FOR ISOMERIZING GLUCOSE IN FRUCTOSE
DE3874610D1 (en)
ES533422A0 (en) PROCEDURE FOR PREPARING CULTIVATION CELLS IN SUSPENSION OF SUNFLOWER PLANTS.
HUT49563A (en) Process for producing optically active hydroxy-benzyl-amin derivatives, optically active amine-boron compounds containing them, and process for producing other optically active compounds with utilizing former optically active amine-boron compounds
ES548544A0 (en) PROCEDURE FOR PREPARING TO ISOLATE AND PURIFY AN ACTIVE POLYPEPTIDE AS AN ANTIBIOTIC.
TR24383A (en) YOENTEM FOR MAKING CONCENTRATED YUEZEY ACTIVE SUBSTANCE GRANUELS
NO890356D0 (en) PROCEDURE FOR AA TO DO ROAD AND MARKET CONSTRUCTIONS.
ES524658A0 (en) MANUFACTURING PROCEDURE FOR A BAND WITH AN ACTIVE LOAD FOR THERAPEUTIC PURPOSES.

Legal Events

Date Code Title Description
PC1A Transfer granted
FD1A Patent lapsed

Effective date: 20061107